Literature DB >> 20503051

Detection of relevant colonic neoplasms with PET/CT: promising accuracy with minimal CT dose and a standardised PET cut-off.

Wolfgang Luboldt1, Teresa Volker, Bärbel Wiedemann, Klaus Zöphel, Ursula Wehrmann, Arne Koch, Todd Toussaint, Nasreddin Abolmaali, Markus Middendorp, Daniela Aust, Jörg Kotzerke, Frank Grünwald, Thomas J Vogl, Hans-Joachim Luboldt.   

Abstract

OBJECTIVE: To determine the performance of FDG-PET/CT in the detection of relevant colorectal neoplasms (adenomas > or =10 mm, with high-grade dysplasia, cancer) in relation to CT dose and contrast administration and to find a PET cut-off.
METHODS: 84 patients, who underwent PET/CT and colonoscopy (n = 79)/sigmoidoscopy (n = 5) for (79 x 6 + 5 x 2) = 484 colonic segments, were included in a retrospective study. The accuracy of low-dose PET/CT in detecting mass-positive segments was evaluated by ROC analysis by two blinded independent reviewers relative to contrast-enhanced PET/CT. On a per-lesion basis characteristic PET values were tested as cut-offs.
RESULTS: Low-dose PET/CT and contrast-enhanced PET/CT provide similar accuracies (area under the curve for the average ROC ratings 0.925 vs. 0.929, respectively). PET demonstrated all carcinomas (n = 23) and 83% (30/36) of relevant adenomas. In all carcinomas and adenomas with high-grade dysplasia (n = 10) the SUV(max) was > or =5. This cut-off resulted in a better per-segment sensitivity and negative predictive value (NPV) than the average PET/CT reviews (sensitivity: 89% vs. 82%; NPV: 99% vs. 98%). All other tested cut-offs were inferior to the SUV(max).
CONCLUSION: FDG-PET/CT provides promising accuracy for colorectal mass detection. Low dose and lack of iodine contrast in the CT component do not impact the accuracy. The PET cut-off SUV(max) > or = 5 improves the accuracy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20503051      PMCID: PMC2914265          DOI: 10.1007/s00330-010-1772-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  65 in total

1.  (18)F-DG PET/CT in detection of recurrence and metastasis of colorectal cancer.

Authors:  Long-Bang Chen; Jin-Long Tong; Hai-Zhu Song; Hong Zhu; Yu-Cai Wang
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

2.  Ability of FDG-PET to detect all cancers in patients with familial adenomatous polyposis, and impact on clinical management.

Authors:  Mariëtte C A van Kouwen; Joost P H Drenth; J Han J M van Krieken; Harry van Goor; Pieter Friederich; Wim J G Oyen; Fokko M Nagengast
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-11-16       Impact factor: 9.236

3.  Extracolonic abnormalities discovered incidentally at CT colonography in a male population.

Authors:  Judy Yee; Naveen N Kumar; Suchitra Godara; Janice A Casamina; Robert Hom; Gregory Galdino; Peter Dell; Darice Liu
Journal:  Radiology       Date:  2005-08       Impact factor: 11.105

4.  Effect of clinicopathologic factors on visibility of colorectal polyps with FDG PET.

Authors:  Masatoyo Nakajo; Seishi Jinnouchi; Yukie Tashiro; Hiroshi Shirahama; Eiichi Sato; Chihaya Koriyama; Masayuki Nakajo
Journal:  AJR Am J Roentgenol       Date:  2009-03       Impact factor: 3.959

5.  18-Fluorodeoxyglucose positron emission tomography has limited sensitivity for colonic adenoma and early stage colon cancer.

Authors:  Shai Friedland; Roy Soetikno; Marie Carlisle; Alan Taur; Tonya Kaltenbach; George Segall
Journal:  Gastrointest Endosc       Date:  2005-03       Impact factor: 9.427

6.  Clinical significance of unexplained abnormal focal FDG uptake in the abdomen during whole-body PET.

Authors:  Neeta Pandit-Taskar; Heiko Schöder; Mithat Gonen; Steven M Larson; Henry W D Yeung
Journal:  AJR Am J Roentgenol       Date:  2004-10       Impact factor: 3.959

7.  CT colonography and colonoscopy: assessment of patient preference in a 5-week follow-up study.

Authors:  Rogier E van Gelder; Erwin Birnie; Jasper Florie; Michiel P Schutter; Joep F Bartelsman; Pleun Snel; Johan S Laméris; Gouke J Bonsel; Jaap Stoker
Journal:  Radiology       Date:  2004-09-09       Impact factor: 11.105

8.  Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison.

Authors:  Harry Agress; Benjamin Z Cooper
Journal:  Radiology       Date:  2003-12-29       Impact factor: 11.105

9.  Prospective evaluation of whole-body cancer screening with multiple modalities including [18F]fluorodeoxyglucose positron emission tomography in a healthy population: a preliminary report.

Authors:  Sadahiko Nishizawa; Shinsuke Kojima; Satoshi Teramukai; Masayuki Inubushi; Hironobu Kodama; Yoshiki Maeda; Hiroyuki Okada; Bin Zhou; Yoji Nagai; Masanori Fukushima
Journal:  J Clin Oncol       Date:  2009-03-02       Impact factor: 44.544

10.  Application of positron emission tomography imaging to cancer screening.

Authors:  S Yasuda; M Ide; H Fujii; T Nakahara; Y Mochizuki; W Takahashi; A Shohtsu
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

View more
  12 in total

1.  Incidental 18F-FDG uptake in the colon: value of contrast-enhanced CT correlation with colonoscopic findings.

Authors:  Julian Kirchner; Benedikt M Schaarschmidt; Firas Kour; Lino M Sawicki; Ole Martin; Johannes Bode; Stephan Vom Dahl; Verena Keitel; Dieter Häussinger; Christina Antke; Christian Buchbender; Gerald Antoch; Philipp Heusch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-07       Impact factor: 9.236

2.  Incidental colonic focal FDG uptake on PET/CT: can the maximum standardized uptake value (SUVmax) guide us in the timing of colonoscopy?

Authors:  F B van Hoeij; R G M Keijsers; B C A J Loffeld; G Dun; P H G M Stadhouders; B L A M Weusten
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-20       Impact factor: 9.236

3.  Prevalence and Clinical Significance of Incidental Focal 18F-FDG Uptake in Colon on PET/CT Imaging.

Authors:  Yasemin Gökden; Filiz Özülker; Tamer Özülker
Journal:  Mol Imaging Radionucl Ther       Date:  2022-06-27

4.  Pre-operative TNM staging of primary colorectal cancer by (18)F-FDG PET-CT or PET: a meta-analysis including 2283 patients.

Authors:  Yanwei Ye; Tao Liu; Lisha Lu; Guojun Wang; Min Wang; Jingjing Li; Chao Han; Jianguo Wen
Journal:  Int J Clin Exp Med       Date:  2015-11-15

5.  An FDG-PET/CT-positive lesion mimicking local recurrence of colon cancer 5 years after radical colectomy.

Authors:  Takashi Orii; Motohiro Okumura; Masaki Yoshimura; Hiroe Kitahara; Yukihiko Karasawa
Journal:  Am J Case Rep       Date:  2015-03-12

6.  Positron emission tomography/computed tomography for optimized colon cancer staging and follow up.

Authors:  Bodil Elisabeth Engelmann; Annika Loft; Andreas Kjær; Hans Jørgen Nielsen; Anne Kiil Berthelsen; Tina Binderup; Kim Brinch; Nils Brünner; Thomas Alexander Gerds; Gunilla Høyer-Hansen; Michael Holmsgaard Kristensen; Engin Yeter Kurt; Jan Erik Latocha; Gunnar Lindblom; Carsten Sloth; Liselotte Højgaard
Journal:  Scand J Gastroenterol       Date:  2013-11-29       Impact factor: 2.423

7.  Recent chemotherapy reduces the maximum-standardized uptake value of 18F-fluoro-deoxyglucose positron emission tomography in colorectal cancer.

Authors:  Minjong Lee; Tae Sung Yeum; Ji Won Kim; Sohee Oh; Shin Ae Lee; Hong Ran Moon; Young Hoon Choi; Yoo Min Han; Ji Min Choi; Dong Kee Jang
Journal:  Gut Liver       Date:  2014-05       Impact factor: 4.519

Review 8.  Prevalence and malignancy risk of focal colorectal incidental uptake detected by (18)F-FDG-PET or PET/CT: a meta-analysis.

Authors:  Giorgio Treglia; Silvia Taralli; Marco Salsano; Barbara Muoio; Ramin Sadeghi; Luca Giovanella
Journal:  Radiol Oncol       Date:  2014-04-25       Impact factor: 2.991

9.  Focal colorectal uptake in (18)FDG-PET/CT: maximum standard uptake value as a trigger in a semi-automated screening setting.

Authors:  Wolfgang Luboldt; Baerbel Wiedemann; Sebastian Fischer; Boris Bodelle; Hans Joachim Luboldt; Frank Grünwald; Thomas J Vogl
Journal:  Eur J Med Res       Date:  2016-01-09       Impact factor: 2.175

10.  Limited Identification of Dual-time-point Positron Emission Tomography/Computed Tomography in Advanced Colorectal Neoplasms.

Authors:  Kazuhiro Kashiwagi; Yoshihiro Nakazato; Mari Arai; Eisuke Iwasaki; Makoto Naganuma; Nagamu Inoue; Yasushi Iwao; Haruhiko Ogata; Koji Murakami; Takanori Kanai
Journal:  Intern Med       Date:  2017-06-01       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.